Christian A Gutierrez

This inventor holds 27 USPTO granted patents and 10 published patent applications and 9 EPO patents, primarily in Ophthalmic Devices. Top assignees: Verily Life Sciences LLC, Twenty Twenty Therapeutics LLC, Amgen Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian A Gutierrez. Retrieved from https://idiyas.com/inventor/christian-a-gutierrez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 10)

% Patents Active = 85.2

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 41(Granted Patents)

Location History:

Santa Clara, CA (US) (2018)
San Jose, CA (US) (2018 - 2019)
San Francisco, CA (US) (2020 - 2023)
Pacifica, CA (US) (2021 - 2024)
Thousand Oaks, CA (US) (2024)

Company Filing History:

20 out of 967

Verily Life Sciences LLC

patents

6 out of 23

Twenty Twenty Therapeutics LLC

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Therapeutic Agent Delivery

Smart Contact Lenses

Non-Invasive Treatments

Eye-Mountable Devices

Gesture-Based Algorithms

Ocular Device Interfaces

Patterned Drug Release

Dynamic Visual Field Modulation

Tear-Film Sensing

Inductive Loop Antenna

Periocular Nerve Stimulation

Intraocular Lens

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12722006 - Multidirectional periocular nerve stimulation and associated systems, devices, and methods (2026-09-01),

2. 12554150 - Creating an interface between a control system and an electronic eyemounted ocular device on pre-existing eyeglasses (2026-02-17),

3. 12508156 - Achieving uniform patterned drug release via at least one embedded microchannel in an ophthalmic device (2025-12-30),

4. 12285356 - Programmable therapeutic agent delivery from eye mounted device (2025-04-29),

5. 12167978 - Eye mounted device for therapeutic agent release (2024-12-17),

6. 12127976 - Eye-mountable therapeutic devices, and associated systems and methods (2024-10-29),

7. 12017071 - Non-invasive periocular device for dry-eye treatment (2024-06-25),

8. 12000775 - System suitability method for use with protein concentration determination by slope (2024-06-04),

9. 11672697 - Eye-mountable therapeutic devices, and associated systems and methods (2023-06-13),

10. 11668956 - Efficient gesture-based contact lens algorithms for human to contact lens communication (2023-06-06),

11. 11464674 - Programmable therapeutic agent delivery from eye mounted device (2022-10-11),

12. 11399976 - Eye mounted device for therapeutic agent release (2022-08-02),

13. 11376432 - Non-invasive periocular device for dry-eye treatment (2022-07-05),

14. 11311373 - Ophthalmic system including accommodating intraocular lens and remote component and related methods of use (2022-04-26),

15. 11298537 - Non-invasive periocular device for dry-eye treatment and closed-loop methods for operating same (2022-04-12),

Title: Innovations by Christian A. Gutierrez in Eye-Mounted Therapeutic Devices

Introduction

Christian A. Gutierrez, based in San Jose, California, is a prolific inventor with an impressive portfolio of 22 patents. His work primarily focuses on the development of advanced therapeutic devices aimed at improving eye care, particularly for conditions such as glaucoma.

Latest Patents

Among his latest innovations are two significant patents related to eye-mounted devices for the controlled release of therapeutic agents. The first patent describes an eye-mounted device designed to deliver therapeutic agents directly to treatment sites in the eye. This device features a polymeric substrate with various regions for optimal delivery, including one or more reservoirs containing the therapeutic agent, and an advanced controlled release mechanism.

The second patent introduces eye-mountable therapeutic devices enabling chronotherapeutic treatment of primary open-angle glaucoma. This device includes a sensor to monitor the eye's condition and a processor that utilizes measurements to activate a therapeutic agent delivery assembly, ensuring that medication is administered at the appropriate time for maximum effectiveness.

Career Highlights

Christian has contributed his expertise to notable companies in the healthcare technology sector, including Verily Life Sciences and Twenty Twenty Therapeutics. His experience in these organizations has bolstered his innovative approach to developing devices that enhance the precision and efficacy of eye treatments.

Collaborations

Throughout his career, Christian has collaborated with talented professionals such as Shungneng Lee and Dmytro Reznikov. These collaborations have undoubtedly expanded his capacity for innovation and enabled the realization of groundbreaking advancements in eye care technology.

Conclusion

Christian A. Gutierrez stands out as a key inventor in the realm of therapeutic eye devices, exemplifying a forward-thinking approach to medical technology. His patents not only reflect his commitment to innovation but also hold the potential to significantly impact the way eye conditions are treated in the future.

Profile summary based on public USPTO records.